RxDoctor Payments DataLook up a doctor →

Sridhar Reddy, MD

Internal Medicine · Colorado Springs, CONPI 1033268040

Payments from drug & device makers

$21,458in general payments, 2019–2025

Across 508 payments — averaging $42.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$11K
  • Regeneron Healthcare Solutions, Inc.$2K
  • Novo Nordisk$925
  • Amgen$694
  • AbbVie$669
  • Johnson & Johnson$512
  • plus $6K from 54 others

What the payments were for

  • Consulting fees$1,6648%
  • Speaking & faculty fees$2,45011%
  • Travel & lodging$8,21138%
  • Food & beverage$9,02442%
  • Education$1091%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.22$11,003
Regeneron Healthcare Solutions, Inc.4$1,664
Novo Nordisk56$925
Amgen53$694
AbbVie(2 entities)39$669
Johnson & Johnson32$512
Astellas Pharma US Inc20$511
E.r. Squibb & Sons, L.L.C.25$483
Novartis19$417
Mallinckrodt Hospital Products Inc.17$412
AstraZeneca(2 entities)21$378
Pfizer20$374
Otsuka America Pharmaceutical, Inc.17$306
Bayer19$243
Lilly USA, LLC11$222
ANI Pharmaceuticals, Inc.9$136
Aimmune Therapeutics, Inc.5$130
Abbott6$127
Eisai Inc.7$123
Gilead5$112
Avanir Pharmaceuticals, Inc.7$106
Kowa Pharmaceuticals America, Inc.4$99
Stryker1$97
Sunovion Pharmaceuticals Inc.7$94
Biogen5$93
Daiichi Sankyo Inc.5$91
Merck5$87
Nestle Healthcare Nutrition Inc.5$81
Seqirus USA Inc3$79
Alnylam Pharmaceuticals Inc.3$72
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$71
Paratek Pharmaceuticals, Inc.4$68
Dexcom, Inc.3$65
Amarin Pharma, Inc.3$63
Exact Sciences3$62
Biohaven Pharmaceutical Holding Company Ltd.2$57
Medtronic2$55
Vifor Pharma, Inc.2$53
Sumitomo Pharma America, Inc.3$49
Lucid Diagnostics Inc.2$48
Ossur Americas, Inc.2$43
Abiomed1$42
Boehringer Ingelheim2$41
GSK2$40
Scilex Pharmaceuticals Inc.2$33
GE HealthCare1$31
Boston Scientific2$30
Insmed, Inc.1$25
Sanofi-aventis U.S. LLC2$25
Shire North American Group Inc1$23
Recordati_rare_diseases_inc.1$23
Kyowa Kirin, Inc.1$21
Calliditas Therapeutics US Inc.1$21
Takeda Pharmaceuticals U.S.A., Inc.1$20
Xeris Pharmaceuticals, Inc.1$18
Sanofi Pasteur Inc.1$17
Edwards Lifesciences1$16
Acadia Pharmaceuticals Inc1$15
Hikma Pharmaceuticals USA1$15
Idorsia Pharmaceuticals US Inc1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,458 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.

See all internal medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$511,841
Medicare patients
589
Services billed
6,202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban56$81,936
OzempicSemaglutide60$69,691
JanuviaSitagliptin Phosphate49$54,242
JardianceEmpagliflozin33$44,161
JanumetSitagliptin Phos/Metformin Hcl21$31,623
Tresiba Flextouch U-200Insulin Degludec29$30,500
XareltoRivaroxaban29$22,702
MyrbetriqMirabegron14$20,647
ProliaDenosumab11$19,031
Spiriva HandihalerTiotropium Bromide11$15,312
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$11,845
SymbicortBudesonide/Formoterol Fumarate24$11,246
Spiriva RespimatTiotropium Bromide14$8,286
Lantus SolostarInsulin Glargine,hum.Rec.Anlog51$8,161
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog16$7,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$87$85,86570 claims
PfizerEliquis, Premarin$374$84,39067 claims
Novo NordiskOzempic$925$69,69160 claims
Boehringer IngelheimJardiance, Spiriva Respimat$41$52,44747 claims
AstraZenecaBreztri Aerosphere, Symbicort$378$23,09042 claims
Johnson & JohnsonXarelto$512$22,70229 claims
Astellas Pharma US IncMyrbetriq$511$20,64714 claims
AmgenProlia$694$19,03111 claims
GSKShingrix$40$6,38229 claims
Sumitomo Pharma America, Inc.Gemtesa$49$5,70212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 internal medicine providers in Colorado.

Other internal medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →